Using the CIZ1B Biomarker for Detection of Early-Stage Lung Cancer and Long-Term Follow-Up of Patients with Returning Lung Cancer

What To Know Before Signing Up For Study

Lung cancer causes more deaths than any other cancer in the United States—and is often not found until it has spread and become harder to treat.

We are asking you to consider taking part in a research study of a simple blood test that could make early detection of lung cancer easier, faster, and more available. By detecting a certain protein in the blood, called CIZ1B, this test could help find lung cancer at its earliest stages—before symptoms appear. Joining the study is your choice, and this fact sheet can help you decide if you would like to take part.

Who Can Take Part?

• Adults aged 50 and older
• Those with a 20 pack/year history of smoking or significant secondhand smoke exposure
• Individuals with environmental or occupational exposure to toxins, such as asbestos, arsenic, diesel fumes, silica, and uranium, including exposures while serving in the military
• Those with exposure to radiation/radon

What is Important to Know?

• There are no costs to you or your insurance company for this research
• Taking part in the study does not affect your current medical care—you will have your same healthcare benefits and get your regular treatments from your doctor
• Risks related to taking part in this study are low and are described in the consent form

What is Involved?

• A small blood sample is taken at routine doctor’s visits
• Simple follow-up visits to track any changes over time
• A review of your clinical records, which may give information to find better ways to diagnose lung cancer early

Why Join?

• You can help change early detection of lung cancer and save lives
• Taking part is simple—just a quick blood draw at your regular visits along with routine follow-ups
• You will contribute to vital lung cancer research and help improve care for patients

What To Know Before Signing Up For Study

By filling out the form below, you are showing interest in learning more about taking part in a research study evaluating a simple blood test designed to make early lung cancer detection easier, quicker, and more accessible. By identifying a protein in the blood called CIZ1B, this test may detect lung cancer at its earliest stages—before symptoms develop and when treatments are most likely to succeed.

After you submit the form, our research team will review your information and contact you to discuss next steps.

Confidentiality Note: Your responses will be kept confidential and used only for the purpose of contacting you about this research study. Only authorized Texas IPS research staff will have access to your information.

This form will only take a few minutes to complete.

If you have questions, please contact a member of our research team:

Sofia Curry
scurrey@texasips.com
210.690.7400 ext 502